In B-ALL, BET inhibition causes strong cytotoxic effects, down-regulates the expression of the oncogenes c-myc and IL7R and leads to apoptosis to B-ALL cell lines and primary patient-derived cells [76,77]. The gene discussed is IL7R; the disease is acute lymphoblastic leukemia.